JULIA COENEN: Open Payments
NPI 1053424150 · CHARLOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 30 payments from 15 companies in 2025. Trend: 2023 $979 · 2024 $1,204 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $115 |
| Axsome Therapeutics, Inc. | 4 | $82 |
| ABBVIE INC. | 3 | $57 |
| PFIZER INC. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Lilly USA, LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Phadia US Inc. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, Auvelity, VRAYLAR, REXULTI, CAPLYTA, NURTEC ODT, ImmunoCAP, JARDIANCE.
Industry payments across MI — which companies pay providers there.
